Barcelona, Spain

Josep Mas-Prio

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2012-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Josep Mas-Prio: Innovator in Pain Management

Introduction

Josep Mas-Prio is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmacology, particularly in the development of compounds aimed at pain management. With a total of 2 patents, his work reflects a commitment to advancing therapeutic options for patients suffering from pain.

Latest Patents

Mas-Prio's latest patents include innovative compounds that exhibit dual pharmacological activity. One of his notable inventions is related to methyl-1H-pyrazole alkylamine compounds, which target both the sigma (σ) receptor and the μ-opioid receptor. This invention focuses on the preparation of these compounds, their pharmaceutical compositions, and their therapeutic applications, especially in pain treatment. Another significant patent involves salts of Tramadol and Naproxen, along with their crystalline forms, aimed at enhancing pain treatment efficacy.

Career Highlights

Throughout his career, Josep Mas-Prio has worked with esteemed companies such as Esteve Pharmaceuticals and Laboratorios del Dr. Esteve. His experience in these organizations has allowed him to contribute to the development of innovative pharmaceutical solutions.

Collaborations

Mas-Prio has collaborated with notable colleagues, including Antoni Torrens-Jover and Carmen Almansa-Rosales. These partnerships have further enriched his research and development efforts in the pharmaceutical field.

Conclusion

Josep Mas-Prio stands out as an influential inventor in the realm of pain management, with a focus on developing effective therapeutic compounds. His contributions continue to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…